Cargando…

Discovery of METTL3 Small Molecule Inhibitors by Virtual Screening of Natural Products

N(6)-Methyladenosine (m(6)A) is the most prevalent mRNA modification in mammalian cells that is mainly catalyzed by the methyltransferase complex of methyltransferase-like 3 and methyltransferase-like 14 (METTL3-METTL14). Many lines of evidence suggest that METTL3 plays important roles in several di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Yue, Yuan, Yongliang, Xu, Le, Zhao, Fang, Wang, Wenbin, Xu, Yiping, Tian, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093036/ https://www.ncbi.nlm.nih.gov/pubmed/35571106 http://dx.doi.org/10.3389/fphar.2022.878135

Ejemplares similares

Discovery of Novel IDH1 Inhibitor Through Comparative Structure-Based Virtual Screening
por: Wang, Yuwei, et al.
Publicado: (2020)

Discovery of Novel HPK1 Inhibitors Through Structure-Based Virtual Screening
por: Ge, Huizhen, et al.
Publicado: (2022)

Virtual screening and activity evaluation of multitargeting inhibitors for idiopathic pulmonary fibrosis
por: Wang, Rui, et al.
Publicado: (2022)

A Pipeline for Natural Small Molecule Inhibitors of Endoplasmic Reticulum Stress
por: Correia da Silva, Daniela, et al.
Publicado: (2022)

Discovery of Novel Inhibitors of Indoleamine 2,3-Dioxygenase 1 Through Structure-Based Virtual Screening
por: Zhang, Guoqing, et al.
Publicado: (2018)

Discovery of novel IDH1-R132C inhibitors through structure-based virtual screening
por: Hu, Chujiao, et al.
Publicado: (2022)

QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery
por: Neves, Bruno J., et al.
Publicado: (2018)

Discovery of Potent Disheveled/Dvl Inhibitors Using Virtual Screening Optimized With NMR-Based Docking Performance Index
por: Hori, Kiminori, et al.
Publicado: (2018)

Discovery of potent and noncovalent KRAS(G12D) inhibitors: Structure-based virtual screening and biological evaluation
por: Wang, Yuting, et al.
Publicado: (2022)

Integrating Machine Learning-Based Virtual Screening With Multiple Protein Structures and Bio-Assay Evaluation for Discovery of Novel GSK3β Inhibitors
por: Zhu, Jingyu, et al.
Publicado: (2020)

Hierarchical virtual screening approaches in small molecule drug discovery
por: Kumar, Ashutosh, et al.
Publicado: (2015)

Discovery of Novel Small-Molecule Inhibitors of BRD4 Using Structure-Based Virtual Screening
por: Vidler, Lewis R., et al.
Publicado: (2013)

Discovery of novel benzylquinazoline molecules as p97/VCP inhibitors
por: Zhang, Xiaoyi, et al.
Publicado: (2023)

Microbiota and their metabolites potentiate cancer immunotherapy: Therapeutic target or resource for small molecule drug discovery?
por: Du, Peixin, et al.
Publicado: (2022)

Small Molecule Inhibitors of CRM1
por: Ferreira, Bibiana I., et al.
Publicado: (2020)

Screening for Small Molecule Inhibitors of Statin-Induced APP C-terminal Toxic Fragment Production
por: Poksay, Karen S., et al.
Publicado: (2017)

METTL7B Is Required for Cancer Cell Proliferation and Tumorigenesis in Non-Small Cell Lung Cancer
por: Liu, Dongcheng, et al.
Publicado: (2020)

Novel Regulatory Factors and Small-Molecule Inhibitors of FGFR4 in Cancer
por: Liu, Yanan, et al.
Publicado: (2021)

Identification of a Novel Protein Arginine Methyltransferase 5 Inhibitor in Non-small Cell Lung Cancer by Structure-Based Virtual Screening
por: Wang, Qianqian, et al.
Publicado: (2018)

Small molecule angiotensin converting enzyme inhibitors: A medicinal chemistry perspective
por: Zheng, Wenyue, et al.
Publicado: (2022)

Discovery of genistein derivatives as potential SARS-CoV-2 main protease inhibitors by virtual screening, molecular dynamics simulations and ADMET analysis
por: Liu, Jiawei, et al.
Publicado: (2022)

Discovery and development of Factor Xa inhibitors (2015–2022)
por: Zheng, Wei, et al.
Publicado: (2023)

Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2
por: Chen, Wei, et al.
Publicado: (2021)

Identification of PARP12 Inhibitors By Virtual Screening and Molecular Dynamics Simulations
por: Almeleebia, Tahani M., et al.
Publicado: (2022)

Screening of a Small Molecule Compound Library Identifies Toosendanin as an Inhibitor Against Bunyavirus and SARS-CoV-2
por: Li, Shufen, et al.
Publicado: (2021)

Drugsniffer: An Open Source Workflow for Virtually Screening Billions of Molecules for Binding Affinity to Protein Targets
por: Venkatraman, Vishwesh, et al.
Publicado: (2022)

Pharmacological Validation of ASIC1a as a Druggable Target for Neuroprotection in Cerebral Ischemia Using an Intravenously Available Small Molecule Inhibitor
por: Qi, Xin, et al.
Publicado: (2022)

A Comprehensive Review of Clinical Cardiotoxicity Incidence of FDA-Approved Small-Molecule Kinase Inhibitors
por: Jin, Ying, et al.
Publicado: (2020)

Small-Molecule Inhibitors Overcome Epigenetic Reprogramming for Cancer Therapy
por: Xiao, Wenjing, et al.
Publicado: (2021)

Selumetinib - a potential small molecule inhibitor for osteoarthritis treatment
por: Zheng, Xiaohang, et al.
Publicado: (2022)

Discovery of Small Molecule Inhibitors of the PH Domain Leucine-Rich Repeat Protein Phosphatase (PHLPP) by Chemical and Virtual Screening
por: Sierecki, Emma, et al.
Publicado: (2010)

Discovery of Small Molecule NSC290956 as a Therapeutic Agent for KRas Mutant Non-Small-Cell Lung Cancer
por: Zhang, Jiaxin, et al.
Publicado: (2022)

Natural Small Molecules Targeting NF-κB Signaling in Glioblastoma
por: Uddin, Md. Sahab, et al.
Publicado: (2021)

Renoprotective potentials of small molecule natural products targeting mitochondrial dysfunction
por: Rahman, Md. Ataur, et al.
Publicado: (2022)

Discovery of Novel and Highly Potent Inhibitors of SARS CoV-2 Papain-Like Protease Through Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, Molecular Dynamics Simulations, and Biological Evaluation
por: Tian, Xiaoyan, et al.
Publicado: (2022)

Protein target identification of ginsenosides in skeletal muscle tissues: discovery of natural small-molecule activators of muscle-type creatine kinase
por: Chen, Feiyan, et al.
Publicado: (2020)

Small Molecules, Inhibitors of DNA-PK, Targeting DNA Repair, and Beyond
por: Davidson, David, et al.
Publicado: (2013)

Virtual screening for the discovery of bioactive natural products
por: Rollinger, Judith M., et al.
Publicado: (2008)

Discovery of TMPRSS2 inhibitors from virtual screening
por: Hu, Xin, et al.
Publicado: (2021)

Discovery of Natural Small Molecules Promoting Collagen Secretion by High-Throughput Screening in Caenorhabditis elegans
por: Fang, Jinyang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4f3jov177ocj2fec886tf2uo4e